Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scpharmaceuticals Inc.

5.08
-0.1700-3.24%
Volume:148.15K
Turnover:763.15K
Market Cap:268.18M
PE:-2.70
High:5.31
Open:5.20
Low:5.05
Close:5.25
Loading ...

scPharmaceuticals (NASDAQ:SCPH) adds US$26m to market cap in the past 7 days, though investors from five years ago are still down 41%

Simply Wall St.
·
11 Jul

scPharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
10 Jun

Analysts Offer Insights on Healthcare Companies: scPharmaceuticals (SCPH), 10x Genomics (TXG) and Kura Oncology (KURA)

TIPRANKS
·
19 May

Craig-Hallum Sticks to Its Buy Rating for scPharmaceuticals (SCPH)

TIPRANKS
·
18 May

scPharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

scPharmaceuticals Q1 EPS $(0.37) Misses $(0.30) Estimate, Sales $11.75M Beat $11.63M Estimate

Benzinga
·
15 May

BRIEF-scPharmaceuticals Q1 Revenue USD 11.752 Million Vs. IBES Estimate USD 11.6 Million

Reuters
·
15 May

scPharmaceuticals Inc expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
13 May

scPharmaceuticals Inc expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
09 May

Investors Welcome US-UK Trade Talks as US Futures Surge in Thursday's Premarket

MT Newswires Live
·
08 May

scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences

GlobeNewswire
·
02 May

scPharmaceuticals Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.
·
21 Mar

scPharmaceuticals Is Maintained at Buy by Maxim Group

Dow Jones
·
20 Mar

Q4 2024 scPharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
20 Mar

Maxim Adjusts Price Target on scPharmaceuticals to $12 From $20, Keeps Buy Rating

MT Newswires Live
·
20 Mar

scPharmaceuticals Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Dow Jones
·
20 Mar

scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

GuruFocus.com
·
20 Mar

ScPharmaceuticals, Inc. (SCPH) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
20 Mar

scPharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
20 Mar

scPharmaceuticals Q4 2024 GAAP EPS $(0.35) Beats $(0.38) Estimate, Sales $12.20M Beat $12.08M Estimate

Benzinga
·
20 Mar